DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/2920a3\/emerging_microbiol<\/a>) has announced the addition of the \"Emerging Microbiology Tests and Companies Developing New Technologies and Products\" report to their offering. <\/p>\n This 650-page report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products. <\/p>\n The report contains 650 pages and 47 tables. <\/p>\n Key Topics Covered: <\/p>\n 1. AIDS <\/p>\n 2. Adenovirus <\/p>\n 3. Aeromonas <\/p>\n 4. Anthrax\/Bacillus Anthracis <\/p>\n 5. Arboviruses <\/p>\n 6. Babesiosis <\/p>\n 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea) <\/p>\n 8. Blastocystis Hominis <\/p>\n 9. Brucella <\/p>\n 10. Campylobacter <\/p>\n 11. Candida <\/p>\n 12. Chagas Disease <\/p>\n 13. Chancroid <\/p>\n 14. Chlamydia <\/p>\n 15. Clostridium Difficile <\/p>\n 16. Coronaviruses <\/p>\n 17. Coxsackieviruses <\/p>\n 18. Creutzfeldt-Jakob's Disease <\/p>\n 19. Cryptosporidium Parvum <\/p>\n 20. Cyclospora Cayetanensis <\/p>\n 21. Cytomegalovirus <\/p>\n 22. Ebola Virus <\/p>\n 23. E. Coli <\/p>\n 24. EchoVirus <\/p>\n 25. Encephalitis <\/p>\n 26. Enteroviruses <\/p>\n 27. Epstein-Barr Virus <\/p>\n 28. Giardia Lamblia <\/p>\n 29. Gonorrhea <\/p>\n 30. Granuloma Inguinale <\/p>\n 31. Hantavirus <\/p>\n 32. Helicobacter Pylori <\/p>\n 33. Hepatitis <\/p>\n 34. Herpes Simplex Virus <\/p>\n 35. Human Herpes Virus-6 (HHV-6) <\/p>\n 36. Influenza Viruses <\/p>\n 37. Legionella <\/p>\n 38. Lyme Disease <\/p>\n 39. Lymphogranuloma Venereum (LGV) <\/p>\n 40. Malaria <\/p>\n 41. Measles (Rubeola) <\/p>\n 42. Meningitis <\/p>\n 43. Microsporidium <\/p>\n 44. Mononucleosis <\/p>\n 45. Mumps <\/p>\n 46. Mycoplasma <\/p>\n 47. Papillomaviruses <\/p>\n 48. Parvovirus B19 <\/p>\n 49. Pneumonia <\/p>\n 50. Polyomaviruses <\/p>\n 51. Pseudomonas Aeruginosa <\/p>\n 52. Rabies <\/p>\n 53. Respiratory Syncytial Virus (RSV) <\/p>\n 54. RhinoViruses <\/p>\n 55. RotaVirus (REOVIRUS) <\/p>\n 56. Rubella(MEASLES) <\/p>\n 57. Salmonellosis <\/p>\n 58. Septicemia <\/p>\n 59. Shigellosis <\/p>\n 60. Staphylococcus Aureus <\/p>\n 61. Streptococci <\/p>\n 62. Syphilis <\/p>\n 63. Toxoplasmosis <\/p>\n 64. Trichomonas Vaginalis <\/p>\n 65. Tuberculosis <\/p>\n 66. Vibrio <\/p>\n 67. West Nile Virus <\/p>\n 68. Yersina <\/p>\n For more information visit http:\/\/www.researchandmarkets.com\/research\/2920a3\/emerging_microbiol<\/a> <\/p>\n<\/p>\n The rest is here: DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/2920a3\/emerging_microbiol<\/a>) has announced the addition of the \"Emerging Microbiology Tests and Companies Developing New Technologies and Products\" report to their offering. This 650-page report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products. Continue reading
\nResearch and Markets: Emerging Microbiology Tests and Companies Developing New Technologies and Products<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"